Epithelial Modulation of Airway Smooth Muscle Response to Endothelin-1

1991 ◽  
Vol 144 (2) ◽  
pp. 373-378 ◽  
Author(s):  
Steven R. White ◽  
Darren P. Hathaway ◽  
Jason G. Umans ◽  
Julio Tallet ◽  
Cyril Abrahams ◽  
...  
1999 ◽  
Vol 277 (3) ◽  
pp. L653-L661 ◽  
Author(s):  
Carol A. Hirshman ◽  
Charles W. Emala

Extracellular stimuli induce cytoskeleton reorganization (stress-fiber formation) in cells and Ca2+ sensitization in intact smooth muscle preparations by activating signaling pathways that involve Rho proteins, a subfamily of the Ras superfamily of monomeric G proteins. In airway smooth muscle, the agonists responsible for cytoskeletal reorganization via actin polymerization are poorly understood. Carbachol-, lysophosphatidic acid (LPA)-, and endothelin-1-induced increases in filamentous actin staining are indicative of actin reorganization (filamentous-to-globular actin ratios of 2.4 ± 0.3 in control cells, 6.7 ± 0.8 with carbachol, 7.2 ± 0.8 with LPA, and 7.4 ± 0.9 with endothelin-1; P < 0.001; n = 14 experiments). Although the effect of all agonists was blocked by C3 exoenzyme (inactivator of Rho), only carbachol was blocked by pertussis toxin. Although carbachol-induced actin reorganization was blocked in cells pretreated with antisense oligonucleotides directed against Gαi-2 alone, LPA- and endothelin-1-induced actin reorganization were only blocked when both Gαi-2 and Gqα were depleted. These data indicate that in human airway smooth muscle cells, carbachol induces actin reorganization via a Gαi-2pathway, whereas LPA or endothelin-1 induce actin reorganization via either a Gαi-2 or a Gqα pathway.


1996 ◽  
Vol 118 (1) ◽  
pp. 191-197 ◽  
Author(s):  
Reynold A. Panettieri ◽  
Roy G. Goldie ◽  
Paul J. Rigby ◽  
Andrew J. Eszterhas ◽  
Douglas W.P. Hay

1997 ◽  
Vol 324 (2-3) ◽  
pp. 219-222 ◽  
Author(s):  
Tsuneyuki Takahashi ◽  
Peter J Barnes ◽  
Ivana Kawikova ◽  
Magdi H Yacoub ◽  
Timothy D Warner ◽  
...  

1995 ◽  
Vol 89 (5) ◽  
pp. 323-328 ◽  
Author(s):  
P. Chitano ◽  
R.E. Lucchini ◽  
E. Coser ◽  
A. Papi ◽  
M. Saetta ◽  
...  

1992 ◽  
Vol 263 (3) ◽  
pp. L317-L324 ◽  
Author(s):  
J. P. Noveral ◽  
S. M. Rosenberg ◽  
R. A. Anbar ◽  
N. A. Pawlowski ◽  
M. M. Grunstein

Increased expression of the potent vasoconstrictor and bronchoactive peptide, endothelin-1 (ET-1), has recently been demonstrated in airway epithelial and endothelial cells of asthmatic patients. To identify its potential role in contributing to airway smooth muscle (ASM) hyperplasia, a characteristic feature of asthmatic airways, the mitogenic action of ET-1 was investigated in cultured rabbit ASM cells. ET-1 elicited significant dose-dependent (10(-12)-10(-6) M) increases in ASM cell number, with a mean potency (i.e., -log mean effective dose) of action of 9.82-log M. ET-1 also acutely stimulated intracellular inositol 1,4,5-trisphosphate accumulation. The latter response was blocked by phospholipase C inhibition with neomycin; however, neomycin had no effect on the promitogenic action of ET-1. By contrast, the ASM cell proliferative response to ET-1 was independently inhibited by pertussis toxin, inhibitors of phospholipase A2, cyclooxygenase, and thromboxane A2 (TxA2) synthesis, as well as blockade of the TxA2 receptor. Moreover, in complementary studies, we found that administration of the stable TxA2 mimetics, carbocyclic TxA2 (CTA2) and U-46619, induced ASM cell proliferation and that ET-1 evoked the release of endogenous TxA2 from the ASM cells. Collectively, these observations provide new evidence that 1) ET-1 is a potent mitogen of ASM cells, 2) the promitogenic effect of ET-1 is associated with activation of a pertussis toxin-sensitive G protein coupled to stimulation of phospholipase A2, and 3) the latter mediates ASM cell proliferation via the release and autocrine mitogenic action of TxA2. The findings support a potential role for ET-1 in mediating the characteristic hyperplasia of ASM in asthma.


Sign in / Sign up

Export Citation Format

Share Document